| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Moshe Shoham last filed a Form 4 in October 2017, as Director at MBOT. Moshe Shoham's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,558,390 shares of MBOT. The MBOT filings lean toward selling, a net 283,700 shares.
Moshe Shoham has 2 Form 4 filings on record from September 2017 to October 2017, all as Microbot Medical (MBOT), 2017.
The 17 reported transactions were 17 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $367K.
The largest open-market sale was 250,000 shares of MBOT at an average $1.27 on September 15, 2017, about $316K.
Shares as reported in the last Form 4 for each company; the most recent is from October 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.